Skip to main content

Polaris Partners — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

186
Companies
$10.0B
Total invested
$53.8M
Avg. check
42
Industries
Health Care 13Biotechnology 12Medical 10Therapeutics 8Pharmaceutical 3Medical Device 2+36 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 49–72 of 186
Simon Data
August 2023

Simon Data is the creator of a customer data platform that allows marketers to create complicated client categories.

Advertising · New York$54.0M Series D
Tisento Therapeutics
July 2023

Tisento Therapeutics is a MA-based developer of novel medicines to treat diseases with significant unmet medical needs.

Health Care · Cambridge$81.0M Series A
Gossamer Bio
July 2023

Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products.

Biotechnology · San Diego$212.0M Post-IPO Equity
CubicPV
June 2023

CubicPV is a solar manufacturing company that produces wafers and tandem modules.

Environmental Consulting · Bedford$33.0M Venture - Series Unknown
Candesant Biomedical
June 2023

Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis.

Health Care · San Francisco$35.0M Series B
Cyclerion Therapeutics
May 2023

Cyclerion Therapeutics harnesses the potential of soluble guanylate cyclase (sGC) pharmacology.

Biotechnology · Cambridge$5.0M Post-IPO Equity
Larkspur Biosciences
May 2023

Larkspur Biosciences is a biotechnology business that is developing the next generation of precision immunotherapies to combat cancer.

Biotechnology · Watertown$35.5M Series A
Wellthy
May 2023

Wellthy is a family care concierge service that brings relief to families managing complex or ongoing care situations.

Health Care · New York$25.5M Venture - Series Unknown
Morphic Therapeutic
May 2023

Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.

Biotechnology · Waltham$276.0M Post-IPO Equity
QurAlis
March 2023

QurAlis is a biotechnology company that creates precision medicine solutions to cure ALS and FTD.

Biotechnology · Cambridge$88.0M Series B
Paratus Sciences
February 2023

Paratus Sciences is dedicated to advancing human health and health security by comprehending the biology of bats.

Biotechnology · New York$100.0M Series A
Caledonia Spirits
January 2023

Caledonia Spirits operates a craft distillery firm created to support working landscapes and local agriculture.

Craft Beer · MontpelierSeries C
August Bioservices
December 2022

August Bioservices is an expert, collaborative, drug discovery, clinical development, and clinical manufacturing company.

Biotechnology · Nashville$65.0M Series B
Podimetrics
November 2022

Podimetrics is a care management company with the leading solution to help prevent diabetic foot amputations.

Diabetes · Somerville$25.0M Debt Financing
Jnana Therapeutics
November 2022

Jnana Therapeutics develops innovative therapies using a chemoproteomics drug discovery platform.

Biotechnology · Boston$107.0M Series C
Faraday Pharmaceuticals
November 2022

Faraday Pharmaceuticals is an early-stage therapeutics company focused on developing novel therapies to treat ischemia-reperfusion injury.

Biotechnology · Seattle$52.8M Series C
Folx Health
October 2022

Folx Health is a telehealth platform that provides digital healthcare services designed for the LGBTQIA+ community.

Health Care · Boston$30.0M Series B
Armorblox
September 2022

Armorblox uses deep learning and natural language technologies to protect enterprise communications.

Artificial Intelligence (AI) · SunnyvaleVenture - Series Unknown
Oui Therapeutics
August 2022

Oui Therapeutics is built on science shown to help people manage troubling thoughts.

Health Care · New Haven$26.0M Series A
Amagma Therapeutics
June 2022

Amagma Therapeutics specializes in the discovery and development of antibody therapeutics against inflammatory diseases.

Biotechnology · Waltham$2.3M Venture - Series Unknown
SQZ Biotech
March 2022

SQZ Biotech features a cell engineering technology designed to deliver a diverse set of materials into patient cells.

Biotechnology · Watertown$2.0M Grant
Satellite Bio
March 2022

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.

Biopharma · Newton$82.5M Series A
Quartet Health
February 2022

Quartet Health is a platform that makes it easier for people to get the best mental health care for them.

Health Care · New York$51.4M Venture - Series Unknown
Savage X Fenty
January 2022

Savage X Fenty is a lingerie brand company that offers underwear and other fashion clothes for women.

E-Commerce · El Segundo$125.0M Series C

Where Polaris Partners invests

Health Care13
Biotechnology12
Medical10
Therapeutics8
Pharmaceutical3
Medical Device2

About Polaris Partners's portfolio

How many companies has Polaris Partners invested in?▸

Polaris Partners has invested in 186 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Polaris Partners invest in?▸

Polaris Partners's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Pharmaceutical. The firm invests across 42 different industry categories.

What is Polaris Partners's largest investment?▸

Among tracked funding rounds, Morphic Therapeutic received $276.0M in a Post-IPO Equity round. Polaris Partners's total known invested capital is $10.0B.

What is the average investment size for Polaris Partners?▸

Polaris Partners's average investment size is $53.8M across its portfolio of 186 companies.

What are Polaris Partners's most recent investments?▸

Recent Polaris Partners portfolio additions include Simon Data, Tisento Therapeutics, Gossamer Bio, CubicPV, Candesant Biomedical. These companies were founded in 2020 or later.

Reach the founders behind these 186 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →